Vagal nerve stimulation may effectively reduce seizures in children with Angelman syndrome with treatment-refractory epilepsy, a case series report shows.
Articles by Magdalena Kegel
In rare cases, loss of part of the UBE3A gene can lead to Angelman syndrome, Spanish researchers report. The team at…
Ovid Therapeutics will modify its ongoing Phase 2 trial of OV101 to add adolescents with Angelman syndrome aged 13…
Ovid Therapeutics is recruiting adult patients with Angelman syndrome to a Phase 2 clinical trial of gaboxadol, a compound…
Machine learning methods could improve the ability of clinical trials to detect if treatments targeting the brain — such as for…
The successful development of meaningful therapies for rare diseases such as Angelman syndrome requires scientists to find out what matters…
Agilis Biotherapeutics said its Angelman syndrome gene therapy development is on track, with initial animal studies making way for…
Researchers in India might have identified an enzyme that is crucial to forming connections between neurons. Defects in this enzyme…
A global online Angelman syndrome registry that Australian researchers started in September 2016 has researched a critical mass, its founders…